Details for Patent: 9,987,334
✉ Email this page to a colleague
Summary for Patent: 9,987,334
| Title: | Treatment of short bowel syndrome patients with colon-in-continuity |
| Abstract: | Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide. |
| Inventor(s): | Sanguinetti; Elizabeth L. (Salt Lake City, UT), Marriott; Thomas B. (Sandy, UT), Lopansri; Jennifer (Park City, UT), Blosch; Consuelo M. (Seattle, WA) |
| Assignee: | Shire-NPS Pharmaceuticals, Inc. (Lexington, MA) |
| Application Number: | 15/285,618 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,987,334 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,987,334
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,987,334
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Canada | 2585482 | ⤷ Try a Trial | |||
| Denmark | 1809318 | ⤷ Try a Trial | |||
| European Patent Office | 1809318 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
